The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).

Journal Metrics

  • 8.9CiteScore
  • 3.9Journal Impact Factor
  • 15%Acceptance rate
  • 8 days Submission to first decision
view all metrics

EAN Webinar Series

Reasons to Publish with Us:

  • Author Guidelines support a seamless submission process with transparent and timely peer review.
  • Increase your chance of being published through our Refer & Transfer program for unaccepted manuscripts.
  • Publish in the official EAN journal with double-digit annual growth in submissions and readership.
  • Get your paper into 14,000+ institutions globally for positive impact on your field.
  • A top-ranked neurology journal adding value via guideline publication, special issues and videocasts.

The European Journal of Neurology is also seeking submissions on brain health/protective neurology or aspects of health economics (if they report on data from Europe (WHO definition) or offer a comparison with European data); additionally welcoming Clinical Trial manuscripts. Review our Author Guidelines and submit your manuscript.

Publishing Open Access? Your Open Access fees may be covered. Check now.

Journal scope

 

Skip slideshow
European Journal of Neurology Jes Olesen Award winning article: "Longitudinal motor system changes from acute to chronic spinal cord injury"

European Journal of Neurology Jes Olesen Award winning article: "Longitudinal motor system changes from acute to chronic spinal cord injury"

Virtual Issue: ENE's 30th Anniversary

Celebrating 30 Years of the European Journal of Neurology: Read the Virtual Issue here.

European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)

European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines), available free to read here.

EJoN Videocast

Watch our latest interviews with EJoN authors of select published papers. Go now >>

Articles

ORIGINAL ARTICLE
Open access

Influence of the Gut Microbiota on Acute Ischemic Stroke Functional Outcomes at Three Months

Miquel Lledós, Luís Prats-Sánchez, Elena Muiño, Natalia Cullell, Laia Llucià-Carol, Jara Cárcel-Márquez, Cristina Gallego-Fabrega, Jesús M. Martín-Campos, Rebeca Marín, Ana Aguilera-Simón, Marina Guasch-Jiménez, Garbiñe Ezcurra-Díaz, Pol Camps-Renom, María del Mar Freijo, Joan Martí-Fàbregas, Israel Fernández-Cadenas, 
  •  21 July 2025

Graphical Abstract

Influence of the Gut Microbiota on Acute Ischemic Stroke Functional Outcomes at Three Months Issue 7, 2025

Gut microbiota diversity, composition, and function are associated with ischemic stroke recovery outcomes at three months. Patients with favorable outcomes had greater microbial diversity and enrichment of beneficial commensals, while unfavorable outcomes were linked to increased pathogens and altered microbial pathways.

LETTER TO THE EDITOR
Open access

Letter to the Editor: “Long-Term Persistent Headache After SARS-CoV-2 Infection: A Follow-Up Population-Based Study”

Jianghao Yu, Lu Xu, Tingting Zhou, Jinwei Li, 
  •  18 July 2025
LETTER TO THE EDITOR
Open access

Reply to: “Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account”

Elie Naddaf, 
  •  17 July 2025
LETTER TO THE EDITOR
Open access

Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account

Josef Finsterer, Sinda Zarrouk, 
  •  17 July 2025
ORIGINAL ARTICLE
Open access

Association Between Stress Hyperglycemia Ratio and Parkinson's Disease Across Different Glucose Metabolism Statuses—A Prospective Study From UK Biobank

Haiyan Zhou, Yuzhi Mi, Xiaoyu Zhang, Wen Sun, Wenfang Xu, 
  •  16 July 2025

Graphical Abstract

Association Between Stress Hyperglycemia Ratio and Parkinson's Disease Across Different Glucose Metabolism Statuses—A Prospective Study From UK Biobank Issue 7, 2025

In this large prospective UK Biobank study, elevated stress hyperglycemia ratio (SHR) was independently associated with an increased risk of Parkinson's disease in men—particularly those without diabetes—but not in women or individuals with prediabetes or diabetes.

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

free access

Multiple sclerosis – a review

R. Dobson, G. Giovannoni, 
  •  27-40
  •  9 October 2018
free access

Alzheimer's disease

C. A. Lane, J. Hardy, J. M. Schott, 
  •  59-70
  •  4 September 2017

Parkinson disease

R. Balestrino, A.H.V. Schapira, 
  •  27-42
  •  20 October 2019
Open access

Amyotrophic lateral sclerosis: a clinical review

P. Masrori, P. Van Damme, 
  •  1918-1929
  •  11 June 2020
free access

Huntington's disease: a clinical review

P. McColgan, S. J. Tabrizi, 
  •  24-34
  •  17 August 2017
More articles
free access

Multiple sclerosis – a review

R. Dobson, G. Giovannoni, 
free access

Alzheimer's disease

C. A. Lane, J. Hardy, J. M. Schott, 
free access

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

Peter Y. K. Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden, Bert Avau, Patrik Vankrunkelsven, Jeffrey A. Allen, Shahram Attarian, Patricia H. Blomkwist-Markens, David R. Cornblath, Filip Eftimov, H. Stephan Goedee, Thomas Harbo, Satoshi Kuwabara, Richard A. Lewis, Michael P. Lunn, Eduardo Nobile-Orazio, Luis Querol, Yusuf A. Rajabally, Claudia Sommer, Haluk A. Topaloglu, 
Open access

European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome

Pieter A. van Doorn, Peter Y. K. Van den Bergh, Robert D. M. Hadden, Bert Avau, Patrik Vankrunkelsven, Shahram Attarian, Patricia H. Blomkwist-Markens, David R. Cornblath, H. Stephan Goedee, Thomas Harbo, Bart C. Jacobs, Susumu Kusunoki, Helmar C. Lehmann, Richard A. Lewis, Michael P. Lunn, Eduardo Nobile-Orazio, Luis Querol, Yusuf A. Rajabally, Thirugnanam Umapathi, Haluk A. Topaloglu, Hugh J. Willison, 
Open access

Guillain-Barré syndrome: a comprehensive review

Roberto Bellanti, Simon Rinaldi, 
Open access

Amyotrophic lateral sclerosis: a clinical review

P. Masrori, P. Van Damme, 
free access

Huntington's disease: a clinical review

P. McColgan, S. J. Tabrizi, 
Open access

European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)

Philip Van Damme, Ammar Al-Chalabi, Peter M. Andersen, Adriano Chiò, Philippe Couratier, Mamede De Carvalho, Orla Hardiman, Magdalena Kuźma-Kozakiewicz, Albert Ludolph, Christopher J. McDermott, Jesus S. Mora, Susanne Petri, Katrin Probyn, Evy Reviers, François Salachas, Vincenzo Silani, Ole-Bjørn Tysnes, Leonard H. van den Berg, Gemma Villanueva, Markus Weber, 
Open access

European Academy of Neurology guidelines on the treatment of cluster headache

Arne May, Stefan Evers, Peter J. Goadsby, Massimo Leone, Gian Camillo Manzoni, Julio Pascual, Vanessa Carvalho, Michele Romoli, Katina Aleksovska, Patricia Pozo-Rosich, Rigmor H. Jensen, European Academy of Neurology Task Force, 
Open access

Survival, causes of death and recurrence up to 3 years after stroke: A population‐based study

Joseph Aked, Hossein Delavaran, Arne G. Lindgren, 

Graphical Abstract

Survival, causes of death and recurrence up to 3 years after stroke: A population-based study Issue 12, 2021

Population-based 3-year stroke survival, causes of death and recurrence are presented, along with survival comparisons over three decades. Changes of the pathological mechanism of stroke were common upon recurrence. Survival rates have improved over the last three decades but the improvement rate may be slowing down.

Recent issues

Latest news

More news >